Enterprise Java platform Azul Systems Inc. today announced the acquisition of Payara Services Ltd., a global enterprise-grade ...
“Bill Gates was bitching about us changing JS all the time,” Eich later recalled of the fall of 1996. Microsoft created its ...
While looking to the AI-powered future and dreaming about overcoming productivity lulls of the past, it’s easy to forget about what makes a knowledge management practice a success. “You have to figure ...
Survival Games Minecraft lead says "I'm looking forward to Hytale" personally, but tells curious fans "there are many Minecraft-like games, so I doubt it will change much for us" RPGs After trying ...
USF Civil Engineering students, Isaac Washington and Kent Huerta, take time out of their busy college schedules to go into high schools across Tampa Bay. Nickels only? Grocers warn ending pennies ...
If your healthcare organization doesn’t yet have a formal compliance program, you’re not alone. Smaller providers like assisted living facilities and clinics, – or even larger organizations that never ...
Matthew Alvarado sells cannabis by the book now, but he sold pot illegally and paid the price. He was incarcerated multiple times, and says the Cannabis Reentry Employment Assistance and Training ...
The U.S. Department of Education announced a partnership Wednesday with more than 40 conservative organizations to create programming around civics aimed at the celebration of the 250th anniversary of ...
At first glance, biology and quantum technology seem incompatible. Living systems operate in warm, noisy environments full of constant motion—while quantum technology often requires extreme isolation ...
ECLIPSE registrational program now fully underway, following enrollment of the first patient in ECLIPSE 3 ECLIPSE 3 is designed to compare the combination of tobevibart and elebsiran to bulevirtide in ...
Reducing GHG (greenhouse gas) emissions from our locomotive operations remains a key CPKC sustainability goal and an important issue facing the railway industry. CPKC has made potentially ...
First patient enrolled in ECLIPSE 2 Phase 3 clinical trial evaluating the switch to the combination of tobevibart and elebsiran in patients not achieving undetectable hepatitis delta virus RNA despite ...